Market Highlights:
Immunoassays are highly adaptable which are designed to detect the binding of the specific
antibody to the target analyte. Singleplex immunoassays are generally used to analyze
multiple intracellular and extracellular proteins and gene expression quantification.
The Global Singleplex Immunoassay Market is driven by various factors such as growth in
pharmaceutical and biotechnology sector, growing prevalence of chronic diseases, and
raising awareness about immunoassay. Moreover, increased focus on diagnostic testing and
growing government assistance are fueling the growth of the Global Singleplex
Immunoassay Market. Additionally, many prominent players are engaged in the
development of singleplex immunoassays products to maintain their market position. For
instance, BioVendor develops and markets Q-Plex Human iL-7 kit for singleplex
immunoassays.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6196
On the other hand, stringent FDA regulations and emergence of other immunoassay
technologies many hamper the growth of the market during the forecast period 2018-2023.
Global Key Players:
Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, QIAGEN N.V, Abcam,
Becton Dickinson and Company, Merck Life sciences, Agilent Technologies, BioVendor,
Quanterix, Bio-Techne, Olink, Seegene are some prominent players in this market.
Segmentation:
The Global Singleplex Immunoassay Market is segmented on the basis of the product and
service, type, technology, application, and end user. On the basis of the product and
services, the market is classified as consumables, instruments, and others. The Global
Singleplex Immunoassay Market on the basis of the type is segmented as protein-based
assays, nucleic acid-based assays, cell-based assays and others. On the basis of technology,
the market is segmented into flow cytometry, fluorescence detection, and others. The
Global Singleplex Immunoassay Market, by application, is segmented into research and
development, clinical diagnostics, and others. The research and development are further
segmented into drug discovery & development and biomarker discovery and validation. The
clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular
diseases, autoimmune diseases, nervous system disorders, and metabolism & endocrinology
disorders. On the basis of the end user, the Global Singleplex Immunoassay Market is
segmented as pharmaceutical & biotechnology companies, hospitals & research institutes,
reference laboratories and others.
Access Full Report @ https://www.marketresearchfuture.com/reports/singleplex-
immunoassay-market-6196
Regional Analysis:
The Global Singleplex Immunoassay Market consists of four regions: Americas, Europe, Asia
Pacific and the Middle East & Africa. Americas is expected to account for the largest market
share owing to the presence of a large number of market players, increasing the prevalence
of cancer, immunological diseases, and metabolic diseases. For instance, in 2017, the
American Cancer Society estimated that approximately 1,688,780 new cancer cases were
diagnosed in America. Europe is anticipated to hold the second position in the market owing
to the increasing prevalence of chronic diseases, funding's provided by the government, and
private organizations towards research & development. Asia Pacific is the fastest growing
region in the Global Singleplex Immunoassay Market owing to the growing patient pool,
high incidence of chronic diseases, developing healthcare infrastructure and increasing
research & development activities in the biotechnology sector, and rising healthcare
expenditure. The Middle East and Africa are anticipated to grow steadily due to the presence
of stringent government policies and poor economies, especially in the Africa region.